Vynleads (VYND) Interest Expenses (2025 - 2026)
Vynleads (VYND) posted Interest Expenses of $1986.0 for Q1 2026, up 111.5% on a QoQ basis from $939.0 in Q1 2025, and up 111.5% YoY from $939.0 in Q1 2025.
Vynleads (VYND) Interest Expenses (2025 - 2026) Analysis & Trends
Vynleads (VYND) has reported Interest Expenses for 2 consecutive years, with $1986.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 111.5% year-over-year to $1986.0; the trailing twelve-month figure through Mar 2026 stood at $1986.0 (up 111.5% YoY), and the FY2025 full-year result was $5045.0, down 79.03% from the prior year.
- Interest Expenses advanced to $1986.0 in Q1 2026 per VYND's latest filing, from $939.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1986.0 in Q1 2026 to a low of $939.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 38.62 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 12.59 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | - |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 20.65 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | - |
| 10 | Vynleads | - | - | -2,028.00 | 1,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,986.00 |
| Mar 31, 2026 | 1,986.00 |
| Mar 31, 2025 | 939.00 |
| Mar 31, 2025 | 939.00 |